B超引导下经皮肝穿刺微波消融对原发性肝癌的效果  

Effect of Percutaneous Transhepatic Microwave Ablation on Primary Liver Cancer Guided by B-ultrasound

作　　者：黎福良[1] 陈钦寿[1] 潘思波[1] 黄军伟[1] 何龙光[1] 朱江[2] LI Fu-liang;CHEN Qin-shou;PAN Si-bo;HUANG Jun-wei;HE Long-guang;ZHU Jiang(Department of Hepatobiliary Surgery, Gaozhou People's Hospital,Gaozhou, Guangdong Province, 525200 China;Department of Ultrasound, Gaozhou People's Hospital,Gaozhou, Guangdong Province, 525200 China)

机构地区：[1]广东省高州市人民医院肝胆外科一区,广东高州525200 [2]广东省高州市人民医院超声科,广东高州525200

出　　处：《中外医疗》2019年第21期26-29,共4页China & Foreign Medical Treatment

摘　　要：目的探讨B超引导下经皮肝穿刺微波消融对原发性肝癌的临床效果。方法方便选取2017年1-12月该院收治68例的原发性肝癌患者,将其随机分为两组,研究组和对照组各34例。对照组采用CT引导下肿瘤射频消融进行治疗,研究组采用B超引导下经皮肝穿刺微波消融进行治疗。分析两组原发性肝癌患者的治疗效果,观察比较两组患者的手术时间、住院时间、住院费用、手术效果以及肝功能变化情况。结果研究组患者干预后的手术时间(30.81±1.89)min短于对照组的手术时间(90.04±1.01)min,研究组的术中出血量(23.15±12.21)mL少于对照组(201.71±11.31)mL、术中输血量(12.13±11.44)mL少于对照组(124.89±2.01)mL,差异有统计学意义(t=10.294、20.391、22.125,P<0.05),研究组患者干预后的肿瘤治疗完全缓解率(32例)高于对照组(30例)(χ~2=1.391、2.142, P>0.05),治疗后研究组患者肝功能情况优于对照组,差异有统计学意义(t=15.138、15.224、17.281,P<0.05)。结论原发性肝癌患者采用B超引导下经皮肝穿刺微波消融的临床效果显著,缩短了手术时间和住院时间,减少住院费用,值得在临床上广泛运用和推广。Objective To investigate the clinical effect of percutaneous transhepatic microwave ablation guided by B-ultrasound on primary liver cancer. Methods From January to December 2017, 68 patients with primary liver cancer were convenient selected and enrolled in our hospital. They were randomly divided into two groups, 34 in the study group and the control group each. The control group was treated with CT-guided radiofrequency ablation of the tumor. The study group was treated with B-ultrasound guided percutaneous transhepatic microwave ablation. The therapeutic effects of the two groups of patients with primary liver cancer were analyzed. The operation time, hospitalization time, hospitalization cost,surgical effect and liver function changes were compared between the two groups. Results The operation time of the study group(30.81±1.89)mL was shorter than that of the control group(90.04±1.01)min. The intraoperative blood loss of the study group(23.15±12.21)min was less than that of the control group(201.71±11.31)mL. The amount of blood transfusion(12.13±1.44)mL was lower than that of the control group(124.89±2.01)mL, the difference was statistically significant(t=10.294,20.391, 22.125, P<0.05). The complete response rate of tumor treatment after intervention in the study group(32 cases)were higher than the control group(30 cases)(χ^2=1.391, 2.142, P>0.05). The liver function of the study group was better than that of the control group after treatment. The difference was statistically significant(t=15.138,15.224,17.281, P<0.05).Conclusion The clinical effect of percutaneous transhepatic microwave ablation guided by B-ultrasound in patients with primary liver cancer is significant. It shortens the operation time and hospitalization time and reduces the hospitalization cost. It is worthy of being widely used and promoted in clinical practice.

关 键 词：B超引导 微波消融 原发性肝癌 肝功能指标 

分 类 号：R5[医药卫生—内科学]